Does LMWH reduce venous thromboembolic risk compared to UFH in hospitalized medical patients?
LMWH is superior to UFH for DVT prevention in hospitalized medical patients, though neither treatment impacts overall mortality.
Both UFH and LMWH reduce venous thromboembolic risk in hospitalized medical patients, but neither agent alters mortality. When directly compared, LMWH is more effective in preventing DVT.
Lironne Wein (Mon,) studied this question.